The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis – A case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up

The first reported case of trastuzumab induced interstitial lung disease associated with anti-neutrophil cytoplasmic antibody vasculitis – A case report and a prospective cohort study on the usefulness of neutrophil derived biomarkers in monitoring vasculitis disease activity during follow-up

Targeted therapies against human epidermal growth factor receptor 2 (HER2) are associated with increased interstitial lung disease (ILD). Trastuzumab, lapatinib, pertuzumab, and trastuzumab emtansine have markedly extended HER2 breast cancer survival but current knowledge on how these HER2-targeted...

Full description

Bibliographic Details
Main Authors: Chen-Han Chang, Chiau-Jing Jung, Yi-Ming Huang, Lo Chiao, Yih-Leong Chang, Song-Chou Hsieh, Ching-Hung Lin, Yu-Min Kuo
Format: Article
Language:English
Published: Elsevier 2022-02-01
Series:Breast
Subjects:
Trastuzumab
Antineutrophil cytoplasmic antibody
Interstitial lung disease
Breast cancer
Online Access:http://www.sciencedirect.com/science/article/pii/S096097762100998X

Internet

http://www.sciencedirect.com/science/article/pii/S096097762100998X

Similar Items